Conference Coverage

AUDIO: Challenges, rewards face creators of pediatric oncofertility clinics


 

EXPERT ANALYSIS FROM THE NASPAG ANNUAL MEETING

PHILADELPHIA – Few templates exist for creating a pediatric oncofertility clinic, particularly in the context of the nascent trend of pediatric oncologists treating adults with pediatric cancers.

Dr. Karen Burns is a pediatric oncologist at Cincinnati Children’s Hospital who was part of the team that created that institution’s own oncofertility clinic. She offered tips to others who are interested in creating a similar clinic or who would like to incorporate protocols honoring ASCO’s recent position statement that all persons with cancer deserve the right to have fertility discussed as part of their standard of care.

In this audio interview, from the annual meeting of the North American Society for Pediatric and Adolescent Gynecology, Dr. Burns addresses the challenges of treating adults with pediatric cancers, having conversations about fertility with minors, the role of advance directives in oncofertility, and what burdens oncologists with patients in these situations face and how they can be eased by working with a team.

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

Recommended Reading

ASCO guidelines for fertility preservation affirm oocyte preservation
MDedge Hematology and Oncology
No increased cancer risk in children born after assisted conception
MDedge Hematology and Oncology
Finasteride use in prevention not linked to higher mortality
MDedge Hematology and Oncology
Many women with cancer not told about impaired fertility risk
MDedge Hematology and Oncology
Hormone therapy’s protection against endometrial cancer persists in Women’s Health Initiative follow-up study
MDedge Hematology and Oncology
Exercise protects black women against ER-negative breast cancer
MDedge Hematology and Oncology
Older men with prostate cancer have greater risk of CVD, diabetes after prolonged hormonal therapy
MDedge Hematology and Oncology
Prophylactic oophorectomy cuts all-cause mortality 77% in BRCA mutation carriers
MDedge Hematology and Oncology
Hormone therapy predicted improved lung cancer survival in women
MDedge Hematology and Oncology
FDA panel unanimously backs cobas HPV test as primary screening tool
MDedge Hematology and Oncology